209 related articles for article (PubMed ID: 37373137)
21. Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.
Yu G; Xiong D; Liu Z; Li Y; Chen K; Tang H
J Cell Biochem; 2019 Oct; 120(10):17258-17272. PubMed ID: 31104316
[TBL] [Abstract][Full Text] [Related]
22. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
[TBL] [Abstract][Full Text] [Related]
23. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
24. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
Yang L; Men WL; Yan KM; Tie J; Nie YZ; Xiao HJ
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4837-4845. PubMed ID: 30070320
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
26. Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer.
Kang E; Jung SC; Nam SK; Park Y; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Lee HS
Sci Rep; 2022 Feb; 12(1):2295. PubMed ID: 35145164
[TBL] [Abstract][Full Text] [Related]
27. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
28. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
[TBL] [Abstract][Full Text] [Related]
29. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
32. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
34. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
[TBL] [Abstract][Full Text] [Related]
35. MiR-485-5p as a potential biomarker and tumor suppressor in human colorectal cancer.
Pan Y; Qin J; Sun H; Xu T; Wang S; He B
Biomark Med; 2020 Feb; 14(3):239-248. PubMed ID: 31984757
[No Abstract] [Full Text] [Related]
36. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.
Qiu G; Zhang XB; Zhang SQ; Liu PL; Wu W; Zhang JY; Dai SR
Oncol Lett; 2016 Dec; 12(6):5036-5042. PubMed ID: 28101234
[TBL] [Abstract][Full Text] [Related]
37. MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.
Wang C; Fan HQ; Zhang YW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6119-6130. PubMed ID: 31364112
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.
Takahashi M; Cuatrecasas M; Balaguer F; Hur K; Toiyama Y; Castells A; Boland CR; Goel A
PLoS One; 2012; 7(10):e46684. PubMed ID: 23056401
[TBL] [Abstract][Full Text] [Related]
40. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
Yan S; Jiang Y; Liang C; Cheng M; Jin C; Duan Q; Xu D; Yang L; Zhang X; Ren B; Jin P
J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
